Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I disagree...There is a whole department relegated to looking after this kind of stuff.
I have had this happen to me in a few other tickers over the years.
Something smells here.
I'm going golfing to blow off some steam..fore!!!!!!!!!!!
There is a reality check needed on this board.
It is never a good sign when a stock is halted for compliance reasons.
That is what we are facing right now.
The SEC has given the company 10 days to get things in order.
They also have the authority to extend the halt beyond ten days.
If the company does not comply then the stock will be suspended from trading.
That is the reality.
I have no clue what happens to us as shareholders should that nightmare come to be.
The comfort I get out of all this is that Billy is also holding common shares.
Something here doesn't smell right to me and there may be a motive behind this move.
Why would the SEC have waited all this time to halt the stock?
They have been out of compliance for a while.
Something has brought this onto the SEC's radar and they acted now.
THis is an SEC action..not the Nasdaq...big difference.
The halt is not about big news coming..it is about delinquent paperwork..as JBB tried to point out many times.
Not that we could have done anything about it but many on this board jumped all over him...now there is egg on a lot of faces...
That is not the case here.
GO back and look at the historical price from two years ago...read his post...and then your bs meter will go off.
Why don't you add something of value to this board other than lies and bs?
LOL...np...because a mind is a terrible thing to waste...
sure you did...The fact is if you were in 2 years earlier there would have been nothing stopping you from selling in the huge run...so try again..lol
You have no clue what you invested in..that's very obvious..OWCP is not in the cbd oil business...rotflmao!!!
If you were looking for a quick hit this never was the one..it's a startup...with their aim to develop pharmaceutical therapies.
You want to listen to and take advice from people on message boards you hardly know at all..listen to their hype good bad or otherwise.....you end up where you are now...in the swamp..boy...lol
This is a medium to long term play and the reward will be handsome.
If you've tied your money up and that's a problem then that's on you..not owcp.
You became active on IHUB in May of last year...that was after the huge run..so it's obvious what you did.
You should love the pps..it's budget priced..lol
The expression is.. "your point is moot"...not mute...
Looking into this further it appears Reuters just repeated previous info when the company was viable...that's up to 2015...
Sad that they're passing this off as the most up to date..but I guess if the company is not viable and no longer reporting this is the latest reports they have...we are essentially nothing more than a shell now...
waiting for the case to progress...
I just got an updated Reuters report on UOIP as of mid September 2018 and it states only 1.1 b shares not 1.6
https://www.solresearch.scotiabank.com/Fusion/PDFView?FeedId=696&DocTag=31967406&VersionTag=3I0JJIAN6PMAGQCLV1AKULACCU
It would seem that Reuters is just recycling old info if this is in fact wrong.
Troubling to say the least as my broker is providing me with this info.
It does appear this is old news.....only seems relevant up to 2015.
I don't disagree with anything you've written..I just believe in staying low key until the time is right and we're not quite there yet..imo..:))
Call it superstition.
Been doing this too long and seen to many things go south to be celebrating prematurely.
In case anyone needs a reminder..from July 24, 2018
To our Shareholders,
The last period has been an important time for re-assessing our corporate strategy, consolidating our company and strengthening our abilities to execute our strategy. We believe that the strategic re-assessment that we have carried out over the last few months will be critical to our success.
The field in which we operate is increasingly crowded with unproven products. We believe that the companies that will succeed in such a market, will be the ones which have invested their resources in providing validated proof of efficacy and safety for their products. In the past, we have spoken of “market ready” products. This definition related to formulated products which were potentially marketable without the validation that I have eluded to above. We have made the decision that we do not want to compete in this undifferentiated market. Whilst in the short term, this will delay our commercial development, in the long term, this should be strongly value generating for our company and our shareholders.
In order to undertake this positioning, it was important to strengthen our company financially. In May, we announced the closing of the largest funding in the history of our company – a convertible preferred stock offering for US $5 million to an institutional investor. This funding will provide us with the runway to carry out our planned clinical programs. With respect to strengthening our team, we announced the recruitment of Dr. Oron Yacoby Zeevi, formerly CSO at Neuroderm, as our Chief Scientific Officer in February and we are currently planning additional senior personnel additions to increase our capabilities in clinical development and testing.
In December 2017, we announced that we had received a new permit from the Israeli Medical Cannabis Agency (IMCA) to proceed with safety studies for our cannabis soluble tablet delivery system. We subsequently received Institutional Review Board (IRB) approval from the Sourasky Medical Center in Tel Aviv and from the central Israeli Review Board to conduct these studies. In parallel, we announced the completion of the pre-clinical development of our next generation, orally-disintegrating tablet, the subject of the safety studies described above, and the initiation of these studies is now imminent. This tablet is intended to be a replacement for smoking cannabis in chronic pain syndromes. We also announced late in June that we had completed the first stage of the safety study of our cannabis cream. This initial stage comprised the single dosing of healthy volunteers. We are now waiting final volunteer license approval to initiate the second part of this trial, which comprises the twice daily dosing of healthy volunteers for 6 weeks.
With respect to our timeline going forward, key events till the end of this year include the following:
Completion of the cannabis cream safety study – Q4 2018
Initiation of the Oral Disintegrating Tablet safety study – Q4 2018
Completion of the Nasal Spray animal safety, pharmaco-kinetics and pharmaco-dynamics studies – Q4 2018
Whilst we understand that investors are keen to receive news flow, our clinical programs are complex to initiate in that they require multiple levels of approval from different authorities and the studies themselves are time consuming. These clinical programs are however key to our strategy and our positioning as a company dedicated to the pharmaceutical development of cannabis-based products to meet patients’ needs.
On the commercial front, we have continued our business development activities in key future markets for our products. We will announce more specific developments in this area as soon as definitive agreements have been finalized.
The funding that we have obtained provides us with the resources to carry out our research and development programs and to continue our corporate and commercial development. We look forward to updating you on our progress in the coming months.
Yours sincerely,
Dr. Stanley Hirsch,
Be humble....Anything can happen..gloating often ends up biting you in the as*
for sure...
I have a lot of friends and family in and from Ottawa...I like the city..Interesting place..lots of things to do and culture abounds.
27..feels like 35 here in Waterloo Ontario..hey fellow Canucks!
I think you're correct...then your only recourse would be to deal with the company privately and those shares would probably be worth even less..
I know most of the banter on here is speculative in nature regarding how this gets settled...
I just hope that everyone will be happy but there are many different scenarios for shareholders based on the timing of their buys and the amount of shares held.
I won't be tendering my shares for anything under a dollar and even at 1 dollar I still feel a little hard done by...
because of the huge dollars involved in this litigation.
For those of us that got in a bit later and don't own millions...
1 dollar is the starting point imo.
Easy for you to accept a dollar cuz you're in early......
My first buy was at .005..my average is .0299
I'm looking for 2+++
NO one really knows what's realistic....
Just speculation....
We wait
And what if I don't feel the buyout offer is adequate?
Can I hold out?
ONly been to Cali a few times and the pull for me to stay there was hard to fight....
Love the place , the people, the culture and the scenery both geographic and people wise..
A really neat place...actually the whole west coast of N. America is like another world ...imo
Same to you bro!
Same to you Gary and all fellow Hebes here on the board and our friends in Israel!
Am Yisroel Chai!
I went in August..many years ago...it was amazing...
I have done that exact trip from BC all the way down Hwy 1 to the border with Mexico..breathtaking to say the least.
It's very telling how over the last few days the price was pushed down , then recovered nicely...and volume was up...
Now today there's low volume....
Some tactical maneuvering behind the scenes is going on..with the mm's
Wish I understood it...lol
I can't speak for anyone else...but most of my stocks and those I"m tracking are red today...Thanks Donald.
Actually..they were supoenaed...and their statement was in relation to the time and effort that might be required to supply information in relation to the Friedland Case and that it might be a distraction....
YOu and only you have created links where none exist.
Did you meet your daily quota?
They consider Channbonds patent claims predatory..lol
They encourage companies to buy insurance against predatory patent claims.
They litigate and recover funds.
Nice business model...
But not this time...Bucko.
Fact is..anyone smoking that shit deserves what they get.....
Synthetic party drugs...a lot of which originate in China are full of poisonous garbage...
Even pet food coming from China had poison in it...remember???
So why go down that road...just plain uninformed and stupid.
That's why licensed regulated producers of cannabis products will always be the way to go from a qc perspective.
Right on Tappy!
Sometimes you just have to put your Zomby Hoof down!
The fact of the matter is the pps is irrelevant..If in fact you've been here longer and own more shares then act like it.